MedCu Technologies

Medical Equipment
Therapeutic Area(s):
Diabetics, Wound management, Infection control, Dermatology & Aesthetics
Company Status:
Regulatory Approval

MedCu Technologies is the world’s first provider of wound dressing products that are impregnated with copper particles. This pioneering implementation of copper properties has been developed in over 15 years of intensive research and is protected by over 30 patents, globally. MedCU delivers antimicrobial dressing products that provide a barrier for bacteria contamination, while concurrently supporting the healing process. Such products are ideal for acute, diabetic and chronic wounds.

MedCU wound dressing products are an attractive and better alternative to the silver-based dressing that are widely available in the market. While providing superior antimicrobial benefits, they are a more cost effective solution. This is a significant consideration as cost is often born directly by the patient.  The market of antimicrobial wound dressing is estimated at $1.5Bn in 2018 and introduction of an innovative and accessible product will increase this size by driving new usages.

Copper is a natural mineral essential to the human body. Copper is environment friendly. It has a long history of medicinal use based on its antimicrobial effect dating back to ancient times. The rationale for implementing copper is based on its ability to inhibit microbial growth and to support wound healing.

The MedCu Wound Dressing contains an internal absorbent layer and one or two external non-woven layers, all of which are impregnated with copper particles. Dressings are non-irritant, non-sensitizing, and are available in three configurations, with or without an adhesive contour.

MedCu Technologies is currently also seeking distributors in Europe and other territories.